CONMED (CNMD) vs CapsoVision (CV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed CONMED (CNMD) over the past year, gaining 38.9% versus a loss of 3.6%. CONMED is the larger company by market cap ($1.35 billion vs $352.3 million), about 3.8 times the size. CONMED pays a dividend yielding 0.44%, while CapsoVision does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | CV |
|---|---|---|
| Share price | $45.11 | $6.62 |
| Market cap | $1.35B | $352.25M |
| 1-day change | +1.99% | +1.22% |
| YTD return | +8.94% | -38.82% |
| 1-year return | -3.64% | +38.85% |
| 5-year return | -68.86% | — |
| P/E ratio (TTM) | 24.38 | — |
| Forward P/E | 9.43 | — |
| EPS (TTM) | $1.85 | $-0.45 |
| Dividend yield | 0.44% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| 52-week high | $53.66 | $15.37 |
| 52-week low | $31.44 | $4.38 |
| Distance from 52-week high | -15.93% | -56.93% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +0.86% | +43.50% |
| Average volume | 493.66K | 158.10K |
| Shares outstanding | 29.95M | 53.21M |
| Employees | 3,900 | 99 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CONMED is about 3.8 times larger than CapsoVision by market value ($1.35B vs $352.25M).
- CV has outperformed CNMD by 42.5 percentage points over the past year.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
CNMD vs CV FAQ
Which is bigger, CONMED or CapsoVision?
CONMED (CNMD) is larger, with a market capitalization of $1.35B compared with $352.25M for CapsoVision (CV).
Which stock has performed better over the past year, CNMD or CV?
CV returned +38.85% over the past 12 months, compared with -3.64% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, CONMED or CapsoVision?
CONMED pays a dividend yielding 0.44%, while CapsoVision does not currently pay a regular dividend.
Are CONMED and CapsoVision in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.